Manufacturer of Controlled Substances; Notice of Application, 48780 [05-16465]
Download as PDF
<![CDATA[
48780
Federal Register / Vol. 70, No. 160 / Friday, August 19, 2005 / Notices
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with 21 CFR
1301.34(a), this is notice that on April
8, 2005, Research Triangle Institute,
Kenneth H. Davis Jr., Hermann Building
East Institute Drive, P.O. Box 12194,
Research Triangle Park, North Carolina
27709, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as an importer of
the basic class of controlled substance
listed in Schedule II:
Drug
Schedule
Cocaine (9041) .............................
II
The company plans to import small
quantities of the listed controlled
substance for the National Institute of
Drug Abuse and other clients.
Any manufacturer who is presently,
or is applying to be, registered with DEA
to manufacture such basic classes of
controlled substances may file
comments or objections to the issuance
of the proposed registration and may, at
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than September 19, 2005.
This procedure is to be conducted
simultaneously with and independent
of the procedures described in 21 CFR
1301.34(b), (c), (d), (e) and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substance listed in
Schedule I or II are, and will continue
to be required to demonstrate to the
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a), 21 U.S.C. 823(a), and 21
CFR 1301.34(b), (c),(d),(e) and (f) are
satisfied.
VerDate jul<14>2003
16:47 Aug 18, 2005
Jkt 205001
Dated: August 11, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–16467 Filed 8–18–05; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to Section 1301.33(a) of Title
21 of the Code of Federal Regulations
(CFR), this is notice that on January 26,
2005, Sigma Aldrich Research,
Biochemicals, Inc., 1–3 Strathmore
Road, Natick, Massachusetts 01760,
made application by letter to the Drug
Enforcement Administration (DEA) for
registration as a bulk manufacturer of NBenzylpiperazine (7493), a basic class of
controlled substance listed in Schedule
I.
The company plans to manufacture
the listed controlled substance in bulk
for distribution to its customers.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than October 18, 2005.
Dated: August 12, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–16465 Filed 8–18–05; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00118
Fmt 4703
Sfmt 4703
DEPARTMENT OF LABOR
Employment and Training
Administration
Proposed Information Collection
Request Submitted for Public
Comment and Recommendations;
Labor Certification for the Temporary
Employment of Nonimmigrant Aliens
in Agriculture in the United States;
Administrative Measures To Improve
Program Performance
ACTION:
Notice.
SUMMARY: The Department of Labor, as
part of its continuing effort to reduce
paperwork and respondent burden,
conducts a preclearance consultation
program to provide the general public
and Federal agencies with an
opportunity to comment on proposed
and/or continuing collections of
information in accordance with the
Paperwork Reduction Act of 1995
(PRA95) (44 U.S.C. 3506(c)(A)). This
program helps to ensure that requested
data can be provided in the desired
format, reporting burden (time and
financial resources) is minimized,
collection instruments are clearly
understood, and the impact of collection
requirements on respondents can be
properly assessed. Currently, the
Employment and Training
Administration, Office of National
Programs, is soliciting comments
concerning the proposed extension of
the collection for the Labor Certification
for the Temporary Employment of
Nonimmigrant Aliens in Agriculture in
the Unites States; Administrative
Measures to Improve Program
Performance. A copy of the proposed
Information Collection Request (ICR)
can be obtained by contacting the office
listed below in the addressee section of
this notice.
DATES: Written comments must be
submitted to the office listed in the
addressee’s section below on or before
October 18, 2005.
ADDRESSES: John R. Beverly,
Administrator, Office of National
Programs, U.S. Department of Labor,
Employment and Training
Administration, Room C–4312, 200
Constitution Avenue, NW., Washington,
DC 20210, phone: (202) 693–3010 (this
is not a toll-free number); Fax: (202)
693–2768; e-mail:
ETAperforms@dol.gov.
FOR FURTHER INFORMATION CONTACT:
Gregory Wilson, Program Analyst,
Division of Foreign Labor Certification,
U.S. Department of Labor, Employment
& Training Administration, Room C–
4312, 200 Constitution Avenue, NW.,
E:\FR\FM\19AUN1.SGM
19AUN1
]]>Agencies
[Federal Register Volume 70, Number 160 (Friday, August 19, 2005)]
[Notices]
[Page 48780]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-16465]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on January 26, 2005, Sigma
Aldrich Research, Biochemicals, Inc., 1-3 Strathmore Road, Natick,
Massachusetts 01760, made application by letter to the Drug Enforcement
Administration (DEA) for registration as a bulk manufacturer of N-
Benzylpiperazine (7493), a basic class of controlled substance listed
in Schedule I.
The company plans to manufacture the listed controlled substance in
bulk for distribution to its customers.
Any other such applicant and any person who is presently registered
with DEA to manufacture such a substance may file comments or
objections to the issuance of the proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or objections being sent via regular mail
may be addressed, in quintuplicate, to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, Attention: DEA Federal Register
Representative, Liaison and Policy Section (ODL); or any being sent via
express mail should be sent to DEA Headquarters, Attention: DEA Federal
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria,
Virginia 22301; and must be filed no later than October 18, 2005.
Dated: August 12, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 05-16465 Filed 8-18-05; 8:45 am]
BILLING CODE 4410-09-P
